Actively Recruiting
Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin
Led by Beijing Sino-German Union Cosmetic Institute Co., Ltd. · Updated on 2025-08-06
72
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In total, 72 eligible research participants were recruited in this 56-day study. The participants were divided into two groups-namely the Experimental Group and the Control Group-according to stratified randomization, with 36 participants in each group. Finally, 30 participants in each group were expected to complete the study. In this study, for patients with rosacea accompanied by sensitive skin, differences in repairing effects and other improvements were evaluated after they used LA ROCHE-POSAY CICAPLAST BAUME B5+ and a standard cream for 28 days, as well as differences between the two groups after both groups used LA ROCHE-POSAY CICAPLAST BAUME B5+ for an additional 28 days-via objective instrumental measurements and subjective assessments. Additionally, the safety of the investigational product was evaluated among these individuals.
CONDITIONS
Official Title
Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 to 55 years old
- Diagnosed with erythematous telangiectatic rosacea and either untreated or in a stable state without needing treatment
- Persistent Erythema Assessment Scale score between 1 and 3
- Global Assessment Scale score of 2 or less
- Dry facial skin
- Sensitive skin confirmed by a 10% lactic acid stinging test
You will not qualify if you...
- Pregnant, planning pregnancy, breastfeeding, or within 6 months postpartum
- Presence of other facial skin diseases such as seborrheic dermatitis, systemic lupus erythematosus, facial miliform lupus, contact dermatitis, or hormone-dependent dermatitis
- Severe organ damage, malignant tumors, unstable chronic diseases, acute infections, recent major surgeries or trauma, psychological or mental disorders, or use of medications affecting acne
- Other skin conditions in the test area that interfere with evaluation like dermatitis, eczema, infection, tumors, birthmarks, or scars
- Received physical, chemical, or laser cosmetic treatments unrelated to rosacea within the past 3 months
- Participation in any clinical trial within the past 2 months
- Any other condition deemed inappropriate by the dermatologist
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beijing Sino-German Union Cosmetic Institute Co., Ltd.
Beijing, China
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here